Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Bush league

<< Previous

Bullboard Posts

Next >>

Post by lonc17on Dec 07, 2022 8:09pm

333 Views

Post# 35157877

Bush league

What kind of company tweets a photo of a partially legible poster from a major conference and does not follow up with a formal press release?

What kind of company presents a second poster at the same conference without any follow up comment or press release?

ONC a publicly traded company on the TSX and Nasdaq. They have a legal obligation to release material news in a timely fashion.

Without any press releases traders are left to assume the worst.

Ridiculous, bush league stuff.

Matt might consider starting his own crypto exchange.

<< Previous

Bullboard Posts

Next >>

Junior helium miner will explore record discovery in Q4